PHILADELPHIA, PA / ACCESSWIRE / October 27, 2020 / Kaskela Law LLC announces that it is investigating DermTech, Inc. ("DermTech") (NASDAQ:DMTK) on behalf of the company's stockholders.
The investigation seeks to determine whether DermTech and/or the company's officers and directors have violated the securities laws in connection with recent corporate actions.
DermTech stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585, or by email at skaskela@kaskelalaw.com or online at http://kaskelalaw.com/case/dermtech-inc/, for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
skaskela@kaskelalaw.com
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
SOURCE: Kaskela Law LLC
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.